Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-12-12
1991-12-10
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 8, 530328, C07K 706, A61K 3702
Patent
active
050718363
ABSTRACT:
Peptides of the formula
REFERENCES:
patent: 4118483 (1978-10-01), Konig et al.
patent: 4504467 (1985-03-01), Molloy et al.
patent: 4530920 (1985-07-01), Nestor et al.
patent: 4569927 (1986-02-01), Rivier et al.
Folkers et al., Z. Naturforsch, 42b, (1987), 101-106.
Ljungqvist et al., Biochem. Biophys. Res. Commun., 148, (1987), 849-856.
Bajusz et al., Proc. Natl. Acad. Sci., U.S.A., 85, (1988), 1637-1641.
Hocart et al., J. Med. Chem., 30, (1987), 735-739.
Nestor, Jr. et al., LHRH and its Derivatives, pp. 24-35 (1984).
Dutta, Drugs of the Future, vol. 13, No. 8, pp. 761-787 (1988).
Phillips et al., Life Sciences, vol. 41, No. 17, pp. 2017-2022 (1987).
Nestor, Jr. et al., J. Med. Chem., vol. 31, No. 1, pp. 65-72, (1988).
Kolar Cenek
Konig Wolfgang
Sandow Jurgen K.
Davenport Avis M.
Hoechst Aktiengesellschaft
Lee Lester L.
LandOfFree
Competitive gonadoliberin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Competitive gonadoliberin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Competitive gonadoliberin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1040710